The COBIS III registry is a multi-center, real-world registry of 2nd generation drug-eluting stenting in coronary bifurcation lesions in South Korea. From 21 major coronary intervention centers in Korea, a total of 3,000 patients (anticipated) will be enrolled in this database between January 2010 and December 2014. The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with 2nd generation drug-eluting stents for coronary bifurcation lesions in South Korea.
Study Type
OBSERVATIONAL
Enrollment
2,648
Samsung Medical Center
Seoul, South Korea
Target lesion failure
composite of cardiac death, myocardial infarction, or target lesion revascularization
Time frame: 5 years
Cardiac death
All deaths were considered cardiac cause unless obvious non-cardiac causes could be identified
Time frame: 5 years
Myocardial infarction
an elevation of creatine kinase-myocardial band or troponin level greater than the upper limit of normal with concomitant ischemic symptoms or electrocardiography findings indicative of ischemia
Time frame: 5 years
Target lesion revascularization
repeat PCI of the lesion within 5 mm of the inserted stent
Time frame: 3 years
Stent thrombosis
the Academic Research Consortium as definite, probable, or possible
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.